spacer
spacer

PDBsum entry 2hpp

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
2hpp

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
30 a.a. *
251 a.a. *
79 a.a. *
Ligands
0G7
Waters ×119
* Residue conservation analysis
PDB id:
2hpp
Name: Hydrolase/hydrolase inhibitor
Title: Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin
Structure: Alpha-thrombin light chain. Chain: l. Fragment: unp residues 328-363. Alpha-thrombin heavy chain. Chain: h. Fragment: unp residues 364-622. Prothrombin. Chain: p. Fragment: unp residues 214-292.
Source: Homo sapiens. Human. Organism_taxid: 9606. Bos taurus. Bovine. Organism_taxid: 9913
Biol. unit: Trimer (from PQS)
Resolution:
3.30Å     R-factor:   0.157    
Authors: A.Tulinsky,K.Padmanabhan
Key ref:
R.K.Arni et al. (1993). Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry, 32, 4727-4737. PubMed id: 8387813 DOI: 10.1021/bi00069a006
Date:
28-Apr-93     Release date:   31-Jan-94    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00734  (THRB_HUMAN) -  Prothrombin from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
622 a.a.
30 a.a.
Protein chain
Pfam   ArchSchema ?
P00734  (THRB_HUMAN) -  Prothrombin from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
622 a.a.
251 a.a.
Protein chain
Pfam   ArchSchema ?
P00735  (THRB_BOVIN) -  Prothrombin from Bos taurus
Seq:
Struc:
 
Seq:
Struc:
625 a.a.
79 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chains L, H, P: E.C.3.4.21.5  - thrombin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.

 

 
DOI no: 10.1021/bi00069a006 Biochemistry 32:4727-4737 (1993)
PubMed id: 8387813  
 
 
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
R.K.Arni, K.Padmanabhan, K.P.Padmanabhan, T.P.Wu, A.Tulinsky.
 
  ABSTRACT  
 
Both human and bovine prothrombin fragment 2 (the second kringle) have been cocrystallized separately with human PPACK (D-Phe-Pro-Arg)-thrombin, and the structures of these noncovalent complexes have been determined and refined (R = 0.155 and 0.157, respectively) at 3.3-A resolution using X-ray crystallographic methods. The kringles interact with thrombin at a site that has previously been proposed to be the heparin binding region. The latter is a highly electropositive surface near the C-terminal helix of thrombin abundant in arginine and lysine residues. These form salt bridges with acidic side chains of kringle 2. Somewhat unexpectedly, the negative groups of the kringle correspond to an enlarged anionic center of the lysine binding site of lysine binding kringles such as plasminogens K1 and K4 and TPA K2. The anionic motif is DGDEE in prothrombin kringle 2. The corresponding cationic center of the lysine binding site region has an unfavorable Arg70Asp substitution, but Lys35 is conserved. However, the folding of fragment 2 is different from that of prothrombin kringle 1 and other kringles: the second outer loop possesses a distorted two-turn helix, and the hairpin beta-turn of the second inner loop pivots at Val64 and Asp70 by 60 degrees. Lys35 is located on a turn of the helix, which causes it to project into solvent space in the fragment 2-thrombin complex, thereby devastating any vestige of the cationic center of the lysine binding site. Since fragment 2 has not been reported to bind lysine, it most likely has a different inherent folding conformation for the second outer loop, as has also been observed to be the case with TPA K2 and the urokinase kringle. The movement of the Val64-Asp70 beta-turn is most likely a conformational change accompanying complexation, which reveals a new heretofore unsuspected flexibility in kringles. The fragment 2-thrombin complex is only the second cassette module-catalytic domain structure to be determined for a multidomain blood protein and only the third domain-domain interaction to be described among such proteins, the others being factor Xa without a Gla domain and Ca2+ prothrombin fragment 1 with a Gla domain and a kringle.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20976270 A.M.Tanaka-Azevedo, K.Morais-Zani, R.J.Torquato, and A.S.Tanaka (2010).
Thrombin inhibitors from different animals.
  J Biomed Biotechnol, 2010, 641025.  
20002544 N.J.Mutch, T.Myles, L.L.Leung, and J.H.Morrissey (2010).
Polyphosphate binds with high affinity to exosite II of thrombin.
  J Thromb Haemost, 8, 548-555.  
20974933 Z.Chen, L.A.Pelc, and E.Di Cera (2010).
Crystal structure of prethrombin-1.
  Proc Natl Acad Sci U S A, 107, 19278-19283.
PDB code: 3nxp
19589779 N.S.Petrera, A.R.Stafford, B.A.Leslie, C.A.Kretz, J.C.Fredenburgh, and J.I.Weitz (2009).
Long range communication between exosites 1 and 2 modulates thrombin function.
  J Biol Chem, 284, 25620-25629.  
19640005 S.H.Qureshi, L.Yang, C.Manithody, A.V.Iakhiaev, and A.R.Rezaie (2009).
Mutagenesis studies toward understanding allostery in thrombin.
  Biochemistry, 48, 8261-8270.  
18854941 M.E.Papaconstantinou, P.S.Gandhi, Z.Chen, A.Bah, and E.Di Cera (2008).
Na+ binding to meizothrombin desF1.
  Cell Mol Life Sci, 65, 3688-3697.
PDB code: 3e6p
18956887 O.A.Ozhogina, A.Grishaev, E.L.Bominaar, L.Patthy, M.Trexler, and M.Llinás (2008).
NMR solution structure of the neurotrypsin Kringle domain.
  Biochemistry, 47, 12290-12298.
PDB codes: 2k4r 2k51
18765660 P.Kamath, and S.Krishnaswamy (2008).
Fate of Membrane-bound Reactants and Products during the Activation of Human Prothrombin by Prothrombinase.
  J Biol Chem, 283, 30164-30173.  
18058827 R.E.Saunders, and S.J.Perkins (2008).
CoagMDB: a database analysis of missense mutations within four conserved domains in five vitamin K-dependent coagulation serine proteases using a text-mining tool.
  Hum Mutat, 29, 333-344.  
18779330 S.Lancellotti, S.Rutella, V.De Filippis, N.Pozzi, B.Rocca, and R.De Cristofaro (2008).
Fibrinogen-elongated {gamma} Chain Inhibits Thrombin-induced Platelet Response, Hindering the Interaction with Different Receptors.
  J Biol Chem, 283, 30193-30204.  
17635714 P.E.Bock, P.Panizzi, and I.M.Verhamme (2007).
Exosites in the substrate specificity of blood coagulation reactions.
  J Thromb Haemost, 5, 81-94.  
16784223 J.R.Koeppe, and E.A.Komives (2006).
Amide H/2H exchange reveals a mechanism of thrombin activation.
  Biochemistry, 45, 7724-7732.  
14583605 E.P.Bianchini, R.N.Pike, and B.F.Le Bonniec (2004).
The elusive role of the potential factor X cation-binding exosite-1 in substrate and inhibitor interactions.
  J Biol Chem, 279, 3671-3679.  
14701814 I.M.Verhamme, P.E.Bock, and C.M.Jackson (2004).
The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
  J Biol Chem, 279, 9785-9795.  
15331602 S.Yegneswaran, R.M.Mesters, J.A.Fernández, and J.H.Griffin (2004).
Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex.
  J Biol Chem, 279, 49019-49025.  
12939269 P.J.Anderson, A.Nesset, and P.E.Bock (2003).
Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin.
  J Biol Chem, 278, 44482-44488.  
11724802 I.M.Verhamme, S.T.Olson, D.M.Tollefsen, and P.E.Bock (2002).
Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.
  J Biol Chem, 277, 6788-6798.  
11514680 R.Q.Monteiro, P.E.Bock, M.L.Bianconi, and R.B.Zingali (2001).
Characterization of bothrojaracin interaction with human prothrombin.
  Protein Sci, 10, 1897-1904.  
10625611 P.E.Marque, R.Spuntarelli, L.Juliano, M.Aiach, and B.F.Le Bonniec (2000).
The role of Glu(192) in the allosteric control of the S(2)' and S(3)' subsites of thrombin.
  J Biol Chem, 275, 809-816.  
10660541 R.De Cristofaro, E.De Candia, S.Rutella, and J.I.Weitz (2000).
The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III.
  J Biol Chem, 275, 3887-3895.  
10559748 X.Sun, H.Sheardown, P.Tengvall, and J.L.Brash (2000).
Peptide modified gold-coated polyurethanes as thrombin scavenging surfaces.
  J Biomed Mater Res, 49, 66-78.  
10625440 D.N.Marti, J.Schaller, and M.Llinás (1999).
Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains.
  Biochemistry, 38, 15741-15755.
PDB code: 1b2i
9894338 F.Shi, P.J.Hogg, D.J.Winzor, and C.M.Jackson (1998).
Evidence for multiple enzyme site involvement in the modulation of thrombin activity by products of prothrombin proteolysis.
  Biophys Chem, 75, 187-199.  
9485475 J.H.Han, and D.M.Tollefsen (1998).
Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex.
  Biochemistry, 37, 3203-3209.  
9790668 N.S.Colwell, M.A.Blinder, M.Tsiang, C.S.Gibbs, P.E.Bock, and D.M.Tollefsen (1998).
Allosteric effects of a monoclonal antibody against thrombin exosite II.
  Biochemistry, 37, 15057-15065.  
9535876 P.C.Liaw, J.C.Fredenburgh, A.R.Stafford, A.Tulinsky, R.C.Austin, and J.I.Weitz (1998).
Localization of the thrombin-binding domain on prothrombin fragment 2.
  J Biol Chem, 273, 8932-8939.  
9477942 R.J.Petrovan, J.W.Govers-Riemslag, G.Nowak, H.C.Hemker, G.Tans, and J.Rosing (1998).
Autocatalytic peptide bond cleavages in prothrombin and meizothrombin.
  Biochemistry, 37, 1185-1191.  
9786880 T.H.Lee, T.Rhim, and S.S.Kim (1998).
Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells.
  J Biol Chem, 273, 28805-28812.  
9521645 Y.Chang, I.Mochalkin, S.G.McCance, B.Cheng, A.Tulinsky, and F.J.Castellino (1998).
Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
  Biochemistry, 37, 3258-3271.
PDB code: 5hpg
  9385634 A.Hermann, W.R.Laws, and P.C.Harpel (1997).
Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
  Protein Sci, 6, 2324-2335.  
9305949 D.N.Marti, C.K.Hu, S.S.An, P.von Haller, J.Schaller, and M.Llinás (1997).
Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
  Biochemistry, 36, 11591-11604.  
9325262 J.C.Fredenburgh, A.R.Stafford, and J.I.Weitz (1997).
Evidence for allosteric linkage between exosites 1 and 2 of thrombin.
  J Biol Chem, 272, 25493-25499.  
9353333 J.H.Han, H.C.Côté, and D.M.Tollefsen (1997).
Inhibition of meizothrombin and meizothrombin(desF1) by heparin cofactor II.
  J Biol Chem, 272, 28660-28665.  
9220985 X.He, J.Ye, C.T.Esmon, and A.R.Rezaie (1997).
Influence of Arginines 93, 97, and 101 of thrombin to its functional specificity.
  Biochemistry, 36, 8969-8976.  
8631941 A.van de Locht, M.T.Stubbs, M.Bauer, and W.Bode (1996).
Crystallographic evidence that the F2 kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite.
  J Biol Chem, 271, 3413-3416.  
8662922 C.T.Esmon, and P.Lollar (1996).
Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII.
  J Biol Chem, 271, 13882-13887.  
8924207 P.D.Boxrud, and L.J.Berliner (1996).
Comparison of the active-site conformations of bovine alpha-thrombin and meizothrombin(desF1) by electron spin resonance.
  J Protein Chem, 15, 231-242.  
8652577 S.Söhndel, C.K.Hu, D.Marti, M.Affolter, J.Schaller, M.Llinás, and E.E.Rickli (1996).
Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
  Biochemistry, 35, 2357-2364.  
8703912 V.Arocas, R.B.Zingali, M.C.Guillin, C.Bon, and M.Jandrot-Perrus (1996).
Bothrojaracin: a potent two-site-directed thrombin inhibitor.
  Biochemistry, 35, 9083-9089.  
7568220 H.Brandstetter, M.Bauer, R.Huber, P.Lollar, and W.Bode (1995).
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
  Proc Natl Acad Sci U S A, 92, 9796-9800.
PDB code: 1pfx
7878739 M.T.Stubbs, and W.Bode (1995).
The clot thickens: clues provided by thrombin structure.
  Trends Biochem Sci, 20, 23-28.  
7721771 V.Novokhatny, L.Medved, H.R.Lijnen, and K.Ingham (1995).
Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
  J Biol Chem, 270, 8680-8685.  
8202520 J.P.Sheehan, and J.E.Sadler (1994).
Molecular mapping of the heparin-binding exosite of thrombin.
  Proc Natl Acad Sci U S A, 91, 5518-5522.  
  7756983 J.Vijayalakshmi, K.P.Padmanabhan, K.G.Mann, and A.Tulinsky (1994).
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
  Protein Sci, 3, 2254-2271.
PDB codes: 1hag 1hah 1hai
  8069221 K.Padmanabhan, T.P.Wu, K.G.Ravichandran, and A.Tulinsky (1994).
Kringle-kringle interactions in multimer kringle structures.
  Protein Sci, 3, 898-910.
PDB codes: 1pmk 1pml
7712286 M.T.Stubbs, and W.Bode (1994).
Coagulation factors and their inhibitors.
  Curr Opin Struct Biol, 4, 823-832.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer